Cardinal Partners: Funding, Team & Investors

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2019	Vividion Therapeutics	$82.0M Series B	Jakob Loven	ARCH Venture Partners, Canaan Partners, Cure Ventures, Earlybird Venture Capital, Nextech Invest, VenBio Partners, Versant Ventures, Vivo Capital, Alexandria Venture Investments, Altitude Life Science Ventures, BVF Partners, Casdin Capital, Celgene, Mirae Asset Capital, Mubadala Capital, Trinitas Capital
May 28, 2015	lifeIMAGE	$17.5M Other Equity	ROB Coppedge	Galen Partners, Lrvhealth, MassVentures, Partners Innovation Fund
Sep 16, 2014	Privia Health	$400.0M Other Equity	Thomas Carella	Brighton Health Partners, Health Enterprise Partners, Morgan Noble Healthcare Partners, Pamplona Capital Management
May 1, 2014	QPID Health	$12.0M Series B	Philippe Chambon MD, PHD	Applied Ventures, Matrix, Matter Venture Partners, Massachusetts General Physicians Organization, Matrix Partners, Partners Innovation Fund
Jun 18, 2013	Vitals	$22.0M Series C	—	Greycroft, Health Enterprise Partners, Milestone Venture Partners, Thomas Schnettler
Aug 20, 2012	lifeIMAGE	$4.0M Other Equity	—	Galen Partners, MassVentures, Partners Innovation Fund
Jun 5, 2012	Awarepoint	$14.0M Other Equity	Heritage Group	Avalon Ventures, Jafco Ventures, Kleiner Perkins, NEW Leaf Venture Partners, TOP Tier Capital Partners, Venrock
Jun 1, 2012	Awarepoint	$14.0M Series U	Heritage Group	Base Ventures, Battery Ventures, B Capital Group, H.I.G. Capital, Insight Partners, MSD Capital, Indranil Guha, Sapphire Ventures, Venrock, Avalon Ventures, Jafco Ventures, Kleiner Perkins, NEW Leaf Venture Partners, TOP Tier Capital Partners
Sep 3, 2010	lifeIMAGE	$5.2M Series B	Cardinal Partners	EMC, Lrvhealth, MassVentures, Partners Innovation Fund
Mar 1, 2010	Awarepoint	$10.0M Other Equity	Jafco Ventures	Venrock
Jul 28, 2009	aTyr Pharma	$12.0M Other Equity	—	Paul Schimmel, Alta Partners, Polaris Partners
Nov 26, 2008	Awarepoint	$13.3M Other Equity	Cardinal Partners	Avalon Ventures, Venrock
Apr 1, 2007	aTyr Pharma	$11.0M Series B	David H. Mack, Amir Nashat	Polaris Partners, Imagene

Cardinal Partners operates as a specialized venture capital firm, investing in disruptive healthcare technology-enabled services and life sciences companies. It provides early-stage capital and strategic guidance, building robust enterprises. The firm identifies high-potential ventures, partnering actively to assist with critical aspects from regulatory navigation to securing further funding.

Established in 1996, Cardinal Partners was founded on the principle that focused capital and industry collaboration accelerate pioneering healthcare companies. The firm's principals, drawing on significant operating and investment expertise, cultivate enduring relationships and inform a selective investment approach. This experience underpins their market participation.

The firm's portfolio companies, nascent ventures in health tech and life sciences, are its direct beneficiaries. Cardinal Partners’ vision centers on empowering these companies to develop transformative solutions, addressing unmet needs and advancing the healthcare ecosystem. They strive to cultivate a landscape of successful, innovation-driven enterprises.

Cardinal Partners

Subscribe, Save or Share

Investment Activity

Investments Made

Financial History

Leadership Team

Leadership Team

Deep Dive

Sources

Frequently Asked Questions

Frequently Asked Questions

About

Deep Dive

Sources

Frequently Asked Questions

Leadership Team

Investment Activity

Investments Made